State of Alaska Department of Revenue lessened its position in Xerox Holdings Co. (NYSE:XRX – Get Rating) by 11.9% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 17,521 shares of the information technology services provider’s stock after selling 2,375 shares during […]
Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Rating) announced its earnings results on Thursday. The biopharmaceutical company reported ($0.16) earnings per share for the quarter, meeting the consensus estimate of ($0.16), MarketWatch Earnings reports. Lexicon Pharmaceuticals had a negative net margin of 29,448.99% and a negative return on equity of 65.01%. During the same period in the […]
Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Rating) posted its quarterly earnings results on Thursday. The biopharmaceutical company reported ($0.16) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.16), MarketWatch Earnings reports. Lexicon Pharmaceuticals had a negative net margin of 29,448.99% and a negative return on equity of 65.01%. During the same period […]
Xerox (NYSE:XRX – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “strong sell” rating in a report issued on Tuesday, Zacks.com reports. They presently have a $15.00 price target on the information technology services provider’s stock. Zacks Investment Research‘s price objective indicates a potential downside of 14.14% from the […]
Xerox (NYSE:XRX – Get Rating) had its price objective dropped by research analysts at Morgan Stanley from $15.00 to $13.00 in a note issued to investors on Friday, Benzinga reports. The firm presently has an “underweight” rating on the information technology services provider’s stock. Morgan Stanley’s price objective suggests a potential downside of 23.21% from […]